Nov 13, 2020
1:15
For every 15 shares held, investors received 1.
The split itself did not change the total investment value.
Viridian Therapeutics, Inc. (GETTEX:1S1) operates in the Pharmaceuticals: major industry.
Viridian Therapeutics, Inc. company overviewViridian Therapeutics, Inc.'s most recent stock split was on November 13, 2020. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
Viridian Therapeutics, Inc. (GETTEX:1S1) has split its stock 2 times: a 1-for-15 reverse split on November 7, 2016 and a 1-for-15 reverse split on November 13, 2020.
Viridian Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between November 7, 2016 and November 13, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Viridian Therapeutics, Inc.'s 1-for-15 reverse split on November 13, 2020, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Viridian Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on November 13, 2020, 5 years ago. Companies announce splits in advance, and any new GETTEX:1S1 split will appear on this page.